9th International Adrenal Cancer Symposium

Additional dates:

Completed Event:

November 23, 2024

The 9th International Adrenal Cancer Symposium marks the latest installment in a series of successful global gatherings, with each previous event drawing an impressive assembly of 150-250 participants from across the world. These symposia traditionally encompass a comprehensive range of sessions, spanning both clinical and non-clinical sessions. In this symposium, we aspire to enhance the inclusivity and relevance of the event by introducing a dedicated session tailored specifically for patients and their families. This initiative aims to provide valuable insights, support, and information directly to those impacted by adrenal cancer.

Objectives
At the conclusion of this activity, learners will be able to:

-Identify molecular targets for future translational and clinical research.
-Discuss the appropriate treatment options for both localized and advanced cases of adrenal cancer based on individual patient characteristics.
-Develop effective communication and counseling skills for educating patients and their families about adrenal cancer diagnosis, prognosis, and comprehensive management strategies.

Registration
9th International Adrenal Cancer Symposium – November 22-23, 2024. The symposium will begin at 7:30 AM, Friday, November 22, 2024 and will adjourn at 5:00 PM, Saturday, November 22, 2024. Location: Dan L. Duncan Building, 1155 Pressler Street, Floor 8, Houston, TX 77030, Conference Center Rooms 1-8.

The registration fee includes tuition for the in-person Live Activity. Advanced registration is encouraged, and the deadline for advanced registration is October 22, 2024.
To register, please visit: https://mdanderson.cloud-cme.com/9thAdrenalSymp

Abstracts and Awards
Join us and present your latest research in Houston for the 9th International Adrenal Cancer Symposium! This event brings together the world leaders in adrenocortical carcinoma, offering a platform to present your work.

Abstract Deadlines:

Abstract submission opens: June 15, 2024
Abstract submission deadline: September 15th, 2024
Abstract notification date: September 30, 2024

Abstract Categories:

Clinical
Translational

Submission – All abstracts must be submitted electronically via email to Vania Balderrama Brondani, VBalderrama@mdanderson.org.